Latest filing published 08 Apr 2019 for Mirati Therapeutics, Inc..
Insider track record
Neil Reisman: trading record in brief
Neil Reisman appears in our data through filings on Mirati Therapeutics, Inc. shares, published by SEC (Form 4). We count 5 filings; the first trade dates from 11 January 2019 and the latest from 4 April 2019.
The filings describe grants, exercises and other transfers rather than trades on the open market. Such operations are usually part of compensation schedules, which makes them a weaker signal than an open-market trade.
The latest filing, published on 8 April 2019, reports a transaction in Mirati Therapeutics, Inc. Typically, a trade is published a median of 4 days after it takes place. For comparison, the SEC allows two business days to file a Form 4. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to Neil Reisman
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 54,210 shares0Common StockSEC:0000899243-19-010289:0
- 10,000 shares@ US$27.0040.0% of flowCommon StockSEC:0000899243-19-001254:0
- 15,972 shares@ US$4.059.6% of flowCommon StockSEC:0000899243-19-001254:1
- 5,656 shares@ US$59.5049.9% of flowCommon StockSEC:0000899243-19-001254:2
- 50 shares@ US$60.200.4% of flowCommon StockSEC:0000899243-19-001254:3
5 of 5 declarations
